| abstract |
The present application relates to novel binder drug conjugates (ADCs), active metabolites of such ADCs, methods for preparing such ADCs, uses of such ADCs for the treatment and/or prevention of diseases, and the like ADCs are useful for the preparation of a medicament for the treatment and/or prophylaxis of diseases, in particular, hyperproliferative and/or angiogenic disorders, such as cancer disorders. Such therapies can be implemented as monotherapy or in combination with other agents or other therapeutic measures. |